These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 30885757)

  • 1. A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: From the Medical Board of the National Psoriasis Foundation.
    Baumrin E; Van Voorhees A; Garg A; Feldman SR; Merola JF
    J Am Acad Dermatol; 2019 Jul; 81(1):102-110. PubMed ID: 30885757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases.
    Zhang J; Xie F; Delzell E; Chen L; Winthrop KL; Lewis JD; Saag KG; Baddley JW; Curtis JR
    JAMA; 2012 Jul; 308(1):43-9. PubMed ID: 22760290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of herpes zoster associated with biological therapies for psoriasis and psoriatic arthritis: A systematic review and meta-analysis.
    Zou A; Chen Y; Shi N; Ye Y
    Medicine (Baltimore); 2021 Oct; 100(40):e27368. PubMed ID: 34622837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Therapy for Psoriasis and the Risk of Herpes Zoster: A 500,000 Person-year Study.
    Shalom G; Zisman D; Bitterman H; Harman-Boehm I; Greenberg-Dotan S; Dreiher J; Feldhamer I; Moser H; Hammerman A; Cohen Y; Cohen AD
    JAMA Dermatol; 2015 May; 151(5):533-8. PubMed ID: 25797026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study.
    Zhang J; Delzell E; Xie F; Baddley JW; Spettell C; McMahan RM; Fernandes J; Chen L; Winthrop K; Curtis JR
    Arthritis Res Ther; 2011; 13(5):R174. PubMed ID: 22024532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of herpes zoster during biological therapy for psoriasis and other inflammatory conditions.
    Adelzadeh L; Jourabchi N; Wu JJ
    J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):846-52. PubMed ID: 25081573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation.
    Chat VS; Ellebrecht CT; Kingston P; Gondo G; Bell S; Cordoro KM; Desai SR; Duffin KC; Feldman SR; Garg A; Gelfand JM; Gladman D; Green LJ; Gudjonsson J; Han G; Hawkes JE; Kircik L; Koo J; Langley R; Lebwohl M; Michael Lewitt G; Liao W; Martin G; Orbai AM; Reddy SM; Richardson V; Ritchlin CT; Schwartzman S; Siegel EL; Van Voorhees AS; Wallace EB; Weinberg JM; Winthrop KL; Yamauchi P; Armstrong AW
    J Am Acad Dermatol; 2024 Jun; 90(6):1170-1181. PubMed ID: 38331098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for herpes zoster: should people with asthma or COPD be vaccinated?
    Safonova E; Yawn BP; Welte T; Wang C
    Respir Res; 2023 Jan; 24(1):35. PubMed ID: 36709298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shingrix for Herpes Zoster: A Review.
    Shah RA; Limmer AL; Nwannunu CE; Patel RR; Mui UN; Tyring SK
    Skin Therapy Lett; 2019 Jul; 24(4):5-7. PubMed ID: 31339679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of treated anxiety and treated depression among patients with psoriasis and psoriatic arthritis treated with apremilast compared to biologics, DMARDs and corticosteroids: a cohort study in the United States MarketScan database.
    Vasilakis-Scaramozza C; Persson R; Hagberg KW; Jick S
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1755-1763. PubMed ID: 31981426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low rates of vaccination among atopic dermatitis, alopecia areata, psoriasis, and psoriatic arthritis patients on biologics.
    Hren MG; Khattri S
    Arch Dermatol Res; 2024 May; 316(6):285. PubMed ID: 38796548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic literature review to assess the burden of herpes zoster disease in China.
    Yin D; Van Oorschot D; Jiang N; Marijam A; Saha D; Wu Z; Tang H; Diaz-Decaro J; Watson P; Xie X; Ren Y; He Y; Feng Y
    Expert Rev Anti Infect Ther; 2021 Feb; 19(2):165-179. PubMed ID: 32997550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and management of herpes zoster in patients with rheumatoid arthritis and psoriatic arthritis: a clinical review.
    Winthrop KL; Tanaka Y; Lee EB; Wollenhaupt J; Al Enizi A; Azevedo VF; Curtis JR
    Clin Exp Rheumatol; 2022 Jan; 40(1):162-172. PubMed ID: 34128786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies.
    Elyoussfi S; Thomas BJ; Ciurtin C
    Rheumatol Int; 2016 May; 36(5):603-12. PubMed ID: 26892034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy.
    Yun H; Xie F; Delzell E; Chen L; Levitan EB; Lewis JD; Saag KG; Beukelman T; Winthrop K; Baddley JW; Curtis JR
    Arthritis Care Res (Hoboken); 2015 May; 67(5):731-6. PubMed ID: 25201241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of therapies for skin symptoms of psoriasis in patients with psoriatic arthritis: a systematic review.
    Boehncke WH; Alvarez Martinez D; Solomon JA; Gottlieb AB
    J Rheumatol; 2014 Nov; 41(11):2301-5. PubMed ID: 25362715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination.
    Yun H; Yang S; Chen L; Xie F; Winthrop K; Baddley JW; Saag KG; Singh J; Curtis JR
    Arthritis Rheumatol; 2016 Sep; 68(9):2328-37. PubMed ID: 26990731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes zoster in psoriasis patients treated with tofacitinib.
    Winthrop KL; Lebwohl M; Cohen AD; Weinberg JM; Tyring SK; Rottinghaus ST; Gupta P; Ito K; Tan H; Kaur M; Egeberg A; Mallbris L; Valdez H
    J Am Acad Dermatol; 2017 Aug; 77(2):302-309. PubMed ID: 28711084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriatic arthritis treatment and the risk of herpes zoster.
    Zisman D; Bitterman H; Shalom G; Feldhamer I; Comanesther D; Batat E; Greenberg-Dotan S; Cohen S; Cohen AD
    Ann Rheum Dis; 2016 Jan; 75(1):131-5. PubMed ID: 25261573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine.
    James SF; Chahine EB; Sucher AJ; Hanna C
    Ann Pharmacother; 2018 Jul; 52(7):673-680. PubMed ID: 29457489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.